Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile.

Garcia-Broncano P, Maddali S, Einkauf KB, Jiang C, Gao C, Chevalier J, Chowdhury FZ, Maswabi K, Ajibola G, Moyo S, Mohammed T, Ncube T, Makhema J, Jean-Philippe P, Yu XG, Powis KM, Lockman S, Kuritzkes DR, Shapiro R, Lichterfeld M.

Sci Transl Med. 2019 Nov 27;11(520). pii: eaax7350. doi: 10.1126/scitranslmed.aax7350.

PMID:
31776292
2.

Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care.

Koofhethile CK, Moyo S, Kotokwe KP, Mokgethi P, Muchoba L, Mokgweetsi S, Gaolathe T, Makhema J, Shapiro R, Lockman S, Kanki P, Essex M, Gaseitsiwe S, de Oliveira T, Novitsky V.

Medicine (Baltimore). 2019 Nov;98(47):e18014. doi: 10.1097/MD.0000000000018014.

3.

High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.

Mupfumi L, Moyo S, Shin SS, Wang Q, Zetola N, Molebatsi K, Nnawa J, Kgwaadira BT, Bewlay L, Chebani T, Iketleng T, Mogashoa T, Makhema J, Musonda RM, Essex M, Kasvosve I, Gaseitsiwe S.

AIDS. 2019 Dec 1;33(15):2415-2422. doi: 10.1097/QAD.0000000000002363.

PMID:
31764106
4.

Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.

Seatla KK, Choga WT, Mogwele M, Diphoko T, Maruapula D, Mupfumi L, Musonda RM, Rowley CF, Avalos A, Kasvosve I, Moyo S, Gaseitsiwe S.

PLoS One. 2019 Nov 21;14(11):e0224292. doi: 10.1371/journal.pone.0224292. eCollection 2019.

5.

HIV Exposure but Not Early CMV Infection is Associated with Increased Hospitalization and Decreased Memory T-cell Responses to Tetanus Vaccine.

Smith C, Moraka NO, Ibrahim M, Moyo S, Mayondi G, Kammerer B, Leidner J, Gaseitsiwe S, Li S, Shapiro R, Lockman S, Weinberg A.

J Infect Dis. 2019 Nov 10. pii: jiz590. doi: 10.1093/infdis/jiz590. [Epub ahead of print]

PMID:
31711179
6.

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.

Mogashoa T, Melamu P, Derendinger B, Ley SD, Streicher EM, Iketleng T, Mupfumi L, Mokomane M, Kgwaadira B, Rankgoane-Pono G, Tsholofelo TT, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S.

Pathogens. 2019 Oct 28;8(4). pii: E208. doi: 10.3390/pathogens8040208.

7.

Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study.

Bhebhe L, Anderson M, Souda S, Choga WT, Zumbika E, Shaver ZM, Mbangiwa T, Phinius BB, Banda CC, Melamu P, Musonda RM, Essex M, Blackard JT, Moyo S, Gaseitsiwe S.

BMC Infect Dis. 2019 Oct 22;19(1):875. doi: 10.1186/s12879-019-4514-1.

8.

High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015.

Mupfumi L, Moyo S, Shin SS, Wang Q, Zetola N, Molebatsi K, Nnawa J, Kgwaadira BT, Bewlay L, Chebani T, Iketleng T, Mogashoa T, Makhema J, Musonda RM, Essex M, Kasvosve I, Gaseitsiwe S.

AIDS. 2019 Sep 3. doi: 10.1097/QAD.0000000000002363. [Epub ahead of print]

PMID:
31490231
9.

Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.

Tawe L, MacDuffie E, Narasimhamurthy M, Wang Q, Gaseitsiwe S, Moyo S, Kasvosve I, Shin SS, Zetola NM, Paganotti GM, Grover S.

Int J Cancer. 2019 Jul 20. doi: 10.1002/ijc.32581. [Epub ahead of print]

PMID:
31325316
10.

Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.

Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, Chakalisa U, Bennett K, Leidner J, Manyake K, Mbikiwa AM, Simon SV, Letlhogile R, Mukokomani K, van Widenfelt E, Moyo S, Lebelonyane R, Alwano MG, Powis KM, Dryden-Peterson SL, Kgathi C, Novitsky V, Moore J, Bachanas P, Abrams W, Block L, El-Halabi S, Marukutira T, Mills LA, Sexton C, Raizes E, Gaseitsiwe S, Bussmann H, Okui L, John O, Shapiro RL, Pals S, Michael H, Roland M, DeGruttola V, Lei Q, Wang R, Tchetgen Tchetgen E, Essex M, Lockman S.

N Engl J Med. 2019 Jul 18;381(3):230-242. doi: 10.1056/NEJMoa1812281.

PMID:
31314967
11.

Brief Report: High Rates of Adverse Birth Outcomes in HIV and Syphilis Coinfected Women in Botswana.

Shava E, Moyo S, Zash R, Diseko M, Dintwa EN, Mupfumi L, Mabuta J, Mayondi G, Chen JY, Lockman S, Mmalane M, Makhema J, Shapiro R.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):e135-e140. doi: 10.1097/QAI.0000000000002082.

PMID:
31295173
12.

Genetic diversity of Mycobacterium tuberculosis strains circulating in Botswana.

Mogashoa T, Melamu P, Ley SD, Streicher EM, Iketleng T, Kelentse N, Mupfumi L, Mokomane M, Kgwaadira B, Novitsky V, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S.

PLoS One. 2019 May 7;14(5):e0216306. doi: 10.1371/journal.pone.0216306. eCollection 2019.

13.

Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.

Moraka NO, Moyo S, Mayondi G, Leidner J, Ibrahim M, Smith C, Weinberg A, Li S, Thami PK, Kammerer B, Ajibola G, Musonda R, Shapiro R, Gaseitsiwe S, Lockman S.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):118-124. doi: 10.1097/QAI.0000000000001982.

PMID:
30964806
14.

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.

Moyo S, Gaseitsiwe S, Zahralban-Steele M, Maruapula D, Nkhisang T, Mokaleng B, Mohammed T, Ditlhako TR, Bareng OT, Mokgethi TP, van Widenfelt E, Pretorius-Holme M, Mine MO, Raizes E, Yankinda EK, Wirth KE, Gaolathe T, Makhema JM, Lockman S, Essex M, Novitsky V.

AIDS. 2019 May 1;33(6):1073-1082. doi: 10.1097/QAD.0000000000002166.

15.

Prevalence and capsular type distribution of Streptococcus agalactiae isolated from pregnant women in Namibia and South Africa.

Mukesi M, Iweriebor BC, Obi LC, Nwodo UU, Moyo SR, Okoh AI.

BMC Infect Dis. 2019 Feb 20;19(1):179. doi: 10.1186/s12879-019-3809-6.

16.

The activity of commercial antimicrobials, and essential oils and ethanolic extracts of Olea europaea on Streptococcus agalactiae isolated from pregnant women.

Mukesi M, Iweriebor BC, Obi LC, Nwodo UU, Moyo SR, Okoh AI.

BMC Complement Altern Med. 2019 Jan 30;19(1):34. doi: 10.1186/s12906-019-2445-4.

17.

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay.

Rantshabeng P, Kasvosve I, Ndlovu A, Gaseitsiwe S, Moyo S.

PLoS One. 2019 Jan 30;14(1):e0211260. doi: 10.1371/journal.pone.0211260. eCollection 2019.

18.

Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges.

Iketleng T, Lessells R, Dlamini MT, Mogashoa T, Mupfumi L, Moyo S, Gaseitsiwe S, de Oliveira T.

Tuberc Res Treat. 2018 Dec 9;2018:1298542. doi: 10.1155/2018/1298542. eCollection 2018. Review.

19.

Application of machine learning models in predicting length of stay among healthcare workers in underserved communities in South Africa.

Moyo S, Doan TN, Yun JA, Tshuma N.

Hum Resour Health. 2018 Dec 13;16(1):68. doi: 10.1186/s12960-018-0329-1.

20.

Molecular characterization of hepatitis B virus in blood donors in Botswana.

Choga WT, Anderson M, Zumbika E, Moyo S, Mbangiwa T, Phinius BB, Melamu P, Kayembe MK, Kasvosve I, Sebunya TK, Blackard JT, Essex M, Musonda RM, Gaseitsiwe S.

Virus Genes. 2019 Feb;55(1):33-42. doi: 10.1007/s11262-018-1610-z. Epub 2018 Oct 31.

PMID:
30382563
21.

Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.

Moyo S, Gaseitsiwe S, Mohammed T, Pretorius Holme M, Wang R, Kotokwe KP, Boleo C, Mupfumi L, Yankinda EK, Chakalisa U, van Widenfelt E, Gaolathe T, Mmalane MO, Dryden-Peterson S, Mine M, Lebelonyane R, Bennett K, Leidner J, Wirth KE, Tchetgen Tchetgen E, Powis K, Moore J, Clarke WA, Lockman S, Makhema JM, Essex M, Novitsky V.

PLoS One. 2018 Oct 24;13(10):e0204840. doi: 10.1371/journal.pone.0204840. eCollection 2018.

22.

HIV Exposure and Formula Feeding Predict Under-2 Mortality in HIV-Uninfected Children, Botswana.

Ajibola G, Leidner J, Mayondi GK, van Widenfelt E, Madidimalo T, Petlo C, Moyo S, Mmalane M, Williams PL, Cassidy AR, Shapiro R, Kammerer B, Lockman S.

J Pediatr. 2018 Dec;203:68-75.e2. doi: 10.1016/j.jpeds.2018.08.009. Epub 2018 Oct 11.

23.

Nasal Carriage of Methicillin-Resistant Staphylococcus aureus among Health Care Workers in Tertiary and Regional Hospitals in Dar es Salam, Tanzania.

Joachim A, Moyo SJ, Nkinda L, Majigo M, Rugarabamu S, Mkashabani EG, Mmbaga EJ, Mbembati N, Aboud S, Lyamuya EF.

Int J Microbiol. 2018 Sep 10;2018:5058390. doi: 10.1155/2018/5058390. eCollection 2018.

24.

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Lockman S, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Sep 7;9(9). pii: E453. doi: 10.3390/genes9090453.

25.

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm.

Anderson M, Choga WT, Moyo S, Bell TG, Mbangiwa T, Phinius BB, Bhebhe L, Sebunya TK, Makhema J, Marlink R, Kramvis A, Essex M, Musonda RM, Blackard JT, Gaseitsiwe S.

Genes (Basel). 2018 Aug 21;9(9). pii: E420. doi: 10.3390/genes9090420.

26.

Equity of antiretroviral treatment use in high HIV burden countries: Analyses of data from nationally-representative surveys in Kenya and South Africa.

Moyo S, Young PW, Gouws E, Naidoo I, Wamicwe J, Mukui I, Marsh K, Igumbor EU, Kim AA, Rehle T.

PLoS One. 2018 Aug 10;13(8):e0201899. doi: 10.1371/journal.pone.0201899. eCollection 2018.

27.

Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR.

Tawe L, Grover S, Narasimhamurthy M, Moyo S, Gaseitsiwe S, Kasvosve I, Paganotti GM.

MethodsX. 2018 May 31;5:569-578. doi: 10.1016/j.mex.2018.05.018. eCollection 2018.

28.

Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana.

Seatla KK, Avalos A, Moyo S, Mine M, Diphoko T, Mosepele M, Gaolatlhe T, Rowley CF, Ramaabya D, Jarvis JN, Kasvosve I, Gaseitsiwe S.

AIDS. 2018 Aug 24;32(13):1899-1902. doi: 10.1097/QAD.0000000000001920.

29.

Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jun 1;13(6):e0198711. doi: 10.1371/journal.pone.0198711. eCollection 2018.

30.

Targeted HIV testing at birth supported by low and predictable mother-to-child transmission risk in Botswana.

Ibrahim M, Maswabi K, Ajibola G, Moyo S, Hughes MD, Batlang O, Sakoi M, Auletta-Young C, Vaughan L, Lockman S, Jean-Philippe P, Yu X, Lichterfeld M, Kuritzkes DR, Makhema J, Shapiro RL.

J Int AIDS Soc. 2018 May;21(5):e25111. doi: 10.1002/jia2.25111.

31.

Genetic and epidemiological analysis of norovirus from children with gastroenteritis in Botswana, 2013-2015.

Makhaola K, Moyo S, Lechiile K, Goldfarb DM, Kebaabetswe LP.

BMC Infect Dis. 2018 May 30;18(1):246. doi: 10.1186/s12879-018-3157-y.

32.

Chronic and Occult Hepatitis B Virus Infection in Pregnant Women in Botswana.

Mbangiwa T, Kasvosve I, Anderson M, Thami PK, Choga WT, Needleman A, Phinius BB, Moyo S, Leteane M, Leidner J, Blackard JT, Mayondi G, Kammerer B, Musonda RM, Essex M, Lockman S, Gaseitsiwe S.

Genes (Basel). 2018 May 17;9(5). pii: E259. doi: 10.3390/genes9050259.

33.

Lack of Virological Suppression Among Young HIV-Positive Adults in Botswana.

Novitsky V, Gaolathe T, Mmalane M, Moyo S, Chakalisa U, Yankinda EK, Marukutira T, Holme MP, Sekoto T, Gaseitsiwe S, Musonda R, van Widenfelt E, Powis KM, Khan N, Dryden-Peterson S, Bennett K, Wirth KE, Tchetgen ET, Bachanas P, Mills LA, Lebelonyane R, El-Halabi S, Makhema J, Lockman S, Essex M.

J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):557-565. doi: 10.1097/QAI.0000000000001715.

34.

HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.

Mosepele M, Mohammed T, Mupfumi L, Moyo S, Bennett K, Lockman S, Hemphill LC, Triant VA.

Cardiovasc J Afr. 2018 May/Jun 23;29(3):155-161. doi: 10.5830/CVJA-2018-003. Epub 2018 May 14.

35.

Undisclosed antiretroviral drug use in Botswana: implication for national estimates.

Moyo S, Gaseitsiwe S, Powis KM, Pretorius Holme M, Mohammed T, Zahralban-Steele M, Yankinde EK, Maphorisa C, Abrams W, Lebelonyane R, Manyake K, Sekoto T, Mmalane M, Gaolathe T, Wirth KE, Makhema J, Lockman S, Clarke W, Essex M, Novitsky V.

AIDS. 2018 Jul 17;32(11):1543-1546. doi: 10.1097/QAD.0000000000001862.

36.

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.

Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2018 Aug;34(8):667-671. doi: 10.1089/AID.2017.0135. Epub 2018 Jun 12.

37.

Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana.

Powis KM, Lockman S, Ajibola G, Hughes MD, Bennett K, Leidner J, Batlang O, Botebele K, Moyo S, van Widenfelt E, Makhema J, Petlo C, Jibril HB, McIntosh K, Essex M, Shapiro RL.

South Afr J HIV Med. 2018 Mar 28;19(1):751. doi: 10.4102/sajhivmed.v19i1.751. eCollection 2018.

38.
39.

B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine.

Weinberg A, Lindsey J, Bosch R, Persaud D, Sato P, Ogwu A, Asmelash A, Bwakura-Dangarambezi M, Chi BH, Canniff J, Lockman S, Gaseitsiwe S, Moyo S, Smith CE, Moraka NO, Levin MJ; P1072 and Tshipidi Study Teams.

Front Immunol. 2018 Jan 19;8:2002. doi: 10.3389/fimmu.2017.02002. eCollection 2017.

40.

Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S.

PLoS One. 2018 Jan 31;13(1):e0192030. doi: 10.1371/journal.pone.0192030. eCollection 2018. Erratum in: PLoS One. 2018 Jun 1;13(6):e0198711.

41.

Determinants of excellent/good self-rated health among HIV positive individuals in South Africa: evidence from a 2012 nationally representative household survey.

Mabaso MLH, Zungu NP, Rehle T, Moyo S, Jooste S, Zuma K.

BMC Public Health. 2018 Jan 30;18(1):198. doi: 10.1186/s12889-018-5102-9.

42.

The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana.

N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Oct 10;4(4):ofx222. doi: 10.1093/ofid/ofx222. eCollection 2017 Fall.

43.

High HIV-1 RNA Among Newly Diagnosed People in Botswana.

Novitsky V, Prague M, Moyo S, Gaolathe T, Mmalane M, Yankinda EK, Chakalisa U, Lebelonyane R, Khan N, Powis KM, Widenfelt E, Gaseitsiwe S, Dryden-Peterson SL, Holme MP, De Gruttola V, Bachanas P, Makhema J, Lockman S, Essex M.

AIDS Res Hum Retroviruses. 2018 Mar;34(3):300-306. doi: 10.1089/AID.2017.0214. Epub 2018 Jan 17.

44.

The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana.

Campa A, Baum MK, Bussmann H, Martinez SS, Farahani M, van Widenfelt E, Moyo S, Makhema J, Essex M, Marlink R.

Nutr Diet Suppl. 2017;2017(9):37-45. doi: 10.2147/NDS.S123545. Epub 2017 Jul 14.

45.

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.

Rantshabeng PS, Moyo S, Moraka NO, Ndlovu A, MacLeod IJ, Gaseitsiwe S, Kasvosve I.

BMC Infect Dis. 2017 Nov 25;17(1):731. doi: 10.1186/s12879-017-2832-8.

46.

Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana.

Powis KM, Souda S, Lockman S, Ajibola G, Bennett K, Leidner J, Hughes MD, Moyo S, van Widenfelt E, Jibril HB, Makhema J, Essex M, Shapiro RL.

J Int AIDS Soc. 2017 Nov;20(3). doi: 10.1002/jia2.25021.

47.

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana.

Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT.

Open Forum Infect Dis. 2017 Sep 13;4(4):ofx195. doi: 10.1093/ofid/ofx195. eCollection 2017 Fall.

48.

National South African HIV prevalence estimates robust despite substantial test non-participation.

Harling G, Moyo S, McGovern ME, Mabaso M, Marra G, Bärnighausen T, Rehle T.

S Afr Med J. 2017 Jun 30;107(7):590-594. doi: 10.7196/SAMJ.2017.v107i7.11207.

PMID:
29025448
49.

Erratum to: Prevalence of methicillin-resistant Staphylococcus aureus carriage on admission among patients attending regional hospitals in Dar es Salaam, Tanzania.

Joachim A, Moyo SJ, Nkinda L, Majigo M, Mmbaga E, Mbembati N, Aboud S, Lyamuya EF.

BMC Res Notes. 2017 Sep 19;10(1):488. doi: 10.1186/s13104-017-2812-5.

50.

Prevalence of methicillin-resistant Staphylococcus aureus carriage on admission among patients attending regional hospitals in Dar es Salaam, Tanzania.

Joachim A, Moyo SJ, Nkinda L, Majigo M, Mmbaga E, Mbembati N, Aboud S, Lyamuya EF.

BMC Res Notes. 2017 Aug 22;10(1):417. doi: 10.1186/s13104-017-2668-8. Erratum in: BMC Res Notes. 2017 Sep 19;10 (1):488.

Supplemental Content

Support Center